A detailed history of Sectoral Asset Management Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Sectoral Asset Management Inc holds 141,335 shares of FOLD stock, worth $1.38 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
141,335
Previous 216,844 34.82%
Holding current value
$1.38 Million
Previous $2.15 Million 29.85%
% of portfolio
1.26%
Previous 1.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$9.55 - $12.09 $721,110 - $912,903
-75,509 Reduced 34.82%
141,335 $1.51 Million
Q2 2024

Aug 13, 2024

SELL
$9.04 - $11.75 $37,968 - $49,350
-4,200 Reduced 1.9%
216,844 $2.15 Million
Q1 2024

May 14, 2024

BUY
$11.43 - $14.24 $734,663 - $915,276
64,275 Added 41.0%
221,044 $2.6 Million
Q4 2023

Feb 14, 2024

SELL
$9.97 - $14.52 $6.45 Million - $9.39 Million
-646,695 Reduced 80.49%
156,769 $2.22 Million
Q3 2023

Nov 14, 2023

BUY
$11.78 - $13.86 $866,301 - $1.02 Million
73,540 Added 10.08%
803,464 $9.77 Million
Q2 2023

Aug 11, 2023

BUY
$10.72 - $13.3 $2.25 Million - $2.79 Million
209,942 Added 40.37%
729,924 $9.17 Million
Q1 2023

May 12, 2023

BUY
$10.91 - $13.54 $134,193 - $166,542
12,300 Added 2.42%
519,982 $5.77 Million
Q4 2022

Feb 10, 2023

SELL
$9.89 - $12.7 $642,850 - $825,500
-65,000 Reduced 11.35%
507,682 $6.2 Million
Q3 2022

Nov 10, 2022

BUY
$9.82 - $12.75 $115,876 - $150,450
11,800 Added 2.1%
572,682 $5.98 Million
Q2 2022

Aug 15, 2022

SELL
$6.23 - $11.12 $391,867 - $699,448
-62,900 Reduced 10.08%
560,882 $6.02 Million
Q1 2022

May 10, 2022

SELL
$7.89 - $12.48 $4.88 Million - $7.73 Million
-619,100 Reduced 49.81%
623,782 $5.91 Million
Q4 2021

Feb 11, 2022

SELL
$9.82 - $12.44 $11.5 Million - $14.5 Million
-1,167,722 Reduced 48.44%
1,242,882 $14.4 Million
Q3 2021

Nov 15, 2021

BUY
$8.74 - $11.84 $2.79 Million - $3.78 Million
319,200 Added 15.26%
2,410,604 $23 Million
Q2 2021

Aug 16, 2021

BUY
$8.71 - $10.72 $2.83 Million - $3.48 Million
324,700 Added 18.38%
2,091,404 $20.2 Million
Q1 2021

May 14, 2021

BUY
$9.2 - $23.86 $2.14 Million - $5.54 Million
232,100 Added 15.12%
1,766,704 $17.5 Million
Q4 2020

Feb 12, 2021

SELL
$13.47 - $24.89 $8.34 Million - $15.4 Million
-619,029 Reduced 28.74%
1,534,604 $35.4 Million
Q3 2020

Nov 13, 2020

BUY
$12.89 - $15.89 $5.19 Million - $6.4 Million
402,720 Added 23.0%
2,153,633 $30.4 Million
Q2 2020

Aug 13, 2020

BUY
$8.86 - $15.69 $1.71 Million - $3.03 Million
192,952 Added 12.38%
1,750,913 $26.4 Million
Q1 2020

May 13, 2020

SELL
$6.63 - $11.16 $3.33 Million - $5.6 Million
-502,000 Reduced 24.37%
1,557,961 $14.4 Million
Q4 2019

Feb 12, 2020

SELL
$7.48 - $10.75 $10.3 Million - $14.9 Million
-1,381,961 Reduced 40.15%
2,059,961 $20.1 Million
Q3 2019

Nov 14, 2019

BUY
$8.02 - $13.25 $940,737 - $1.55 Million
117,299 Added 3.53%
3,441,922 $27.6 Million
Q2 2019

Aug 14, 2019

SELL
$10.96 - $14.4 $767,200 - $1.01 Million
-70,000 Reduced 2.06%
3,324,623 $41.5 Million
Q1 2019

May 14, 2019

SELL
$10.04 - $13.92 $16.5 Million - $22.9 Million
-1,641,967 Reduced 32.6%
3,394,623 $46.2 Million
Q4 2018

Feb 12, 2019

BUY
$8.38 - $13.44 $1.42 Million - $2.28 Million
169,300 Added 3.48%
5,036,590 $48.3 Million
Q3 2018

Nov 14, 2018

BUY
$11.6 - $16.54 $13.6 Million - $19.4 Million
1,173,600 Added 31.77%
4,867,290 $58.8 Million
Q2 2018

Aug 13, 2018

BUY
$13.13 - $17.09 $3.78 Million - $4.92 Million
288,149 Added 8.46%
3,693,690 $57.7 Million
Q1 2018

May 15, 2018

BUY
$13.76 - $17.12 $7.63 Million - $9.5 Million
554,772 Added 19.46%
3,405,541 $51.2 Million
Q4 2017

Feb 13, 2018

BUY
$12.51 - $16.24 $5.48 Million - $7.11 Million
437,899 Added 18.15%
2,850,769 $41 Million
Q3 2017

Nov 14, 2017

BUY
$11.74 - $15.78 $28.3 Million - $38.1 Million
2,412,870
2,412,870 $36.4 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.75B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.